acarix Press August 6, 2024 03 May 2023 Helen Ljungdahl Round, Acarix President & CEO presents at Redeye Investor Forum On May 4th at 14.40 Helen Ljungdahl Round, Acarix President & CEO, presents the latest developments in the company at the Redeye In... Continue reading
acarix Press August 6, 2024 02 May 2023 Acarix to present at the 2023 Aktiespararna Share Day in Stockholm Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces that the company will present at the 2023 Aktiespararna Share ... Continue reading
acarix Press August 6, 2024 02 May 2023 Acarix presenterar på Aktiespararnas Aktiedag 2023 i Stockholm Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, meddelar att bolaget kommer att presentera på Aktiespararnas Aktiedag 202... Continue reading
acarix Press August 6, 2024 02 May 2023 The exercise period for Acarix warrants of series 2022:U begins today In December 2022, Acarix AB (publ) (“Acarix” or the “Company”) carried out a rights issue of shares and warrants of series 2022:U (the ... Continue reading
acarix Press August 6, 2024 02 May 2023 Idag inleds nyttjandeperioden för Acarix teckningsoptioner av serie 2022:U Acarix AB (publ) (“Acarix” eller “Bolaget”) genomförde under december 2022 en företrädesemission av aktier och teckningsoptioner av ser... Continue reading
acarix News August 6, 2024 05 Apr 2023 Study published in Heart strengthens diagnostic value of Acarix CADScor System The study confirms that the CADScor System has a very high rule-out accuracy in low-risk patients with chest pains, and potential to re... Continue reading
acarix Press August 6, 2024 03 Apr 2023 Acarix accelerates US commercialization into 30 additional states Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announced a strategic sales partnership with CompleMed, LLC, a nat... Continue reading
acarix Press August 6, 2024 03 Apr 2023 Acarix accelererar kommersialiseringen i USA till ytterligare 30 delstater Acarix, ledare inom akustisk och AI-baserad hjärtdiagnostik, meddelar idag ett nytt strategiskt samarbete med CompleMed, en landstäckan... Continue reading
acarix Press August 6, 2024 14 Mar 2023 Studie publicerad i Heart stärker det diagnostiska värdet av Acarix CADScor System Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, tillkännagav idag publiceringen av en ny studie i den ansedda vetenskapli... Continue reading
acarix Press August 6, 2024 06 Mar 2023 Acarix presents at Redeye: Commercialization Seminar On March 7 at 10.30 CET Helen Ljungdahl Round, CEO of Acarix, presents the latest developments in the company at Redeye. The presentati... Continue reading
acarix Press August 6, 2024 06 Mar 2023 Acarix presenterar på Redeye, Seminarium om kommersialisering Den 7 mars kl 10.30 kommer Helen Ljungdahl Round, VD för Acarix, att presentera den senaste utvecklingen inom företaget. Presentationen... Continue reading
acarix Press August 6, 2024 03 Mar 2023 Acarix to showcase at the 2023 ACC congress Acarix, a leader in acoustic and AI-based cardiac diagnostics, will demonstrate the value of its CADScor System during the American Col... Continue reading